Trials - My Global News: Voices of a New Era

Ivonescimab: New Cancer Drug Outperforms Global Leader

Breakthrough cancer drug Ivonescimab from a Chinese firm outperformed Keytruda in late-stage trials, sparking global attention in biotech.